Table 5.
Correlations between baseline-to-follow-up changes in asthma status measures and changes in A-IQOLS and QOLS scores, with estimates of shared variance, n=147.
| Change in Characteristic |
Association with change in A-IQOLS Score |
Association with change in QOLS Score |
|||||
|---|---|---|---|---|---|---|---|
| Clinical Characteristics | Mean ± SD | r* | p | R2 | r* | p | R2 |
| FEV1 Percent Predicted, pre-bronchodilator† | −0.74 ± 8.06 | 0.10 | 0.22 | 0.01 | −0.08 | 0.32 | 0.01 |
| ACT | 0.79 ± 3.16 | −0.40 | <0.0001 | 0.16 | −0.07 | 0.40 | 0.005 |
| ASUI‡ | 0.04 ± 0.15 | −0.33 | <0.0001 | 0.11 | −0.02 | 0.77 | 0.001 |
| Marks AQLQ | −2.59 ± 7.02 | 0.52 | <0.0001 | 0.27 | −0.005 | 0.96 | <0.01 |
| Mini-AQLQ: Total Score | 0.28 ± 0.78 | −0.55 | <0.0001 | 0.30 | 0.07 | 0.38 | 0.01 |
| Mini-AQLQ: Symptom Score | 0.36 ± 0.93 | −0.45 | <0.0001 | 0.20 | 0.06 | 0.49 | 0.003 |
| PHQ-9 | −1.03 ± 2.96 | 0.20 | 0.01 | 0.04 | −0.16 | 0.053 | 0.03 |
| No. exacerbations requiring OCS§ | 0.01 ± 0.27 | 0.10‖ | 0.24 | 0.01 | 0.01‖ | 0.89 | <0.01 |
| No. asthma-related medical visits¶ | 0.04 ± 0.49 | 0.11‖ | 0.20 | 0.01 | −0.07‖ | 0.41 | <0.01 |
| A-IQOLS | −0.10 ± 0.37 | - | - | - | −0.15 | 0.07 | 0.02 |
| QOLS | −0.10 ± 0.61 | ||||||
Abbreviations: A-IQOLS, Asthma Impact on Quality of Life Scale; QOLS, Flanagan Quality of Life Scale; FEV1, forced expiratory volume in one second; ACT, Asthma Control Test; ASUI, Asthma Symptom Utility Index; Marks AQLQ, Asthma Quality of Life Questionnaire; Mini-AQLQ, Juniper mini-Asthma Quality of Life Questionnaire, total score and symptom sub-scale; PHQ-9, Patient Health Questionnaire.
r=Pearson product-moment correlation
Sample size, n=146.
Sample size, n=146.
OCS (oral corticosteroid) prescription of at least 3 days for an asthma-related diagnosis code (asthma, ICD9 493.x; cough, ICD9 786.2; bronchitis, ICD9 490; upper respiratory infection, ICD(465.9; bronchospasm, ICD9 519.11; or wheezing, CD9 786.07) within 4 weeks preceding enrollment. Courses of OCS separated by >7 days were treated as separate exacerbations. See Asthma outcomes: Exacerbations. Fuhlbrigge, A., et al. J Allergy Clin Immunol, 2012:129(3);S34–S48.
Spearman Rank-Order Correlation.
Outpatient office visit or Urgent Care Clinic visit with asthma diagnosis code (ICD9 493.x) within 4 weeks preceding enrollment. Does not include hospital emergency department visits.